Cat drugs spruiked as potential COVID-19 cures
Two experimental medications for cat coronavirus infections are the latest drugs to be spruiked as potential COVID-19 cures, prompting the TGA to reiterate warnings against online overseas drug purchases.
Known as GS-441524 and GC376, copies of the unapproved drugs are said to be in high demand on the black market because of their success in treating the potentially fatal cat coronavirus disease, feline infectious peritonitis — albeit at hefty prices.